Genmab — Januar 2017
-
-
De nye kræftblockbustere: http://www.proinvestor.com/investornyt/406430/medie-her-er-de-nye-kraeftblockbustere
-
Fint med alle disse kombis. Darzalex er efterhånden med i de fleste.
-
Janssen har en aftale med Roche og BMS om disse forsøg. Så Jansen stiller Darzalex gratis til rådighed, og derved er der ikke royalties til Genmab, på den del der anvendes til disse studier!
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
vi må kunne få en ide om meget de forsøg tegner sig for, hvis J&J oplyser rene dara tal den 24